Bayer S.A. (BVL: BAYERI1)
Health Care · Pharmaceuticals · PE
S/.—
— today · — 1Y
Bayer S.A. (BVL: BAYERI1) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $78.92M.
trading between 14.50 and 20.10.
Tweenvest scores Bayer S.A. across four factors: quality 75/100, value 49/100, growth 0/100. Its strongest factor is quality.
BAYERI1 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $78.92M
- Revenue (TTM)
- $85.79M
- P/E
- 24.98
- EPS
- 0.80
- Dividend yield
- —
- Beta (5Y)
- 0.10
- 52-week high
- S/.20.10
- 52-week low
- S/.14.50
- Avg volume (3M)
- —
- Shares outstanding
- 14.72M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zhengye Biotechnology Holding LimitedNasdaqCM: ZYBT | $81.99M | $1.64 | -5.20% |
| Zhongzhi Pharmaceutical Holdings LimitedSEHK: 3737 | $80.88M | HK$0.74 | -2.65% |
| Nutriband Inc.NasdaqCM: NTRB | $80.84M | $5.95 | -10.53% |
| High Tech Pharm Co., Ltd.KOSDAQ: A106190 | $79.09M | ₩10,000.00 | -1.57% |
| NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo ReszvenytarsasagBUSE: NATURLAND | $78.72M | Ft1,860.00 | -21.85% |
| Laboratorios Richmond S.A.C.I.F.BASE: RICH | $78.57M | AR$1,475.00 | -4.22% |
| The IBN SINA Pharmaceutical Industry PLCDSE: IBNSINA | $78.13M | Tk308.00 | -2.22% |
| Stablecoin Development CorporationNYSEAM: SDEV | $77.95M | $1.54 | -22.61% |
Figures last refreshed Oct 11, 2026.